BIT:REC - Euronext Milan - IT0003828271 - Common Stock - Currency: EUR
Overall REC gets a fundamental rating of 5 out of 10. We evaluated REC against 52 industry peers in the Pharmaceuticals industry. While REC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. REC is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.07% | ||
ROE | 22.55% | ||
ROIC | 15.08% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 28.09% | ||
PM (TTM) | 18.65% | ||
GM | 68.03% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.69 | ||
Debt/FCF | 3.29 | ||
Altman-Z | 4.76 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.38 | ||
Quick Ratio | 0.93 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 27.32 | ||
Fwd PE | 18.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 23.65 | ||
EV/EBITDA | 15.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.3% |
BIT:REC (3/7/2025, 7:00:00 PM)
53.55
0 (0%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.3% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 27.32 | ||
Fwd PE | 18.1 | ||
P/S | 4.94 | ||
P/FCF | 23.65 | ||
P/OCF | 21.11 | ||
P/B | 5.97 | ||
P/tB | N/A | ||
EV/EBITDA | 15.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.07% | ||
ROE | 22.55% | ||
ROCE | 19.33% | ||
ROIC | 15.08% | ||
ROICexc | 16.23% | ||
ROICexgc | 111.87% | ||
OM | 28.09% | ||
PM (TTM) | 18.65% | ||
GM | 68.03% | ||
FCFM | 20.87% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.69 | ||
Debt/FCF | 3.29 | ||
Debt/EBITDA | 1.61 | ||
Cap/Depr | 35.41% | ||
Cap/Sales | 2.5% | ||
Interest Coverage | 7.56 | ||
Cash Conversion | 66.49% | ||
Profit Quality | 111.93% | ||
Current Ratio | 1.38 | ||
Quick Ratio | 0.93 | ||
Altman-Z | 4.76 |